Completed

Effects of Inulin and Resistant Starch on Postprandial SCFA, Glucose, Insulin, and Gut Hormone Responses in Lean and Overweight Subjects

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to investigate how Inulin and Resistant Starch affect post-meal responses of certain gut hormones, glucose, insulin, and a specific fatty acid called acetate in both lean and overweight individuals.

What is being tested

Glucose

+ Inulin

+ Resistant Starch

Other
Who is being recruted

Body Weight+5

+ Nutrition Disorders

+ Nutritional and Metabolic Diseases

From 18 to 65 Years
+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Basic Science Study

Interventional
Study Start: February 2012
See protocol details

Summary

Principal SponsorUniversity of Toronto
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2012

Actual date on which the first participant was enrolled.

This study explores how two types of fermentable fibers, inulin and resistant starch, affect certain body responses in lean and overweight or obese individuals. The body naturally breaks down these fibers into short-chain fatty acids (SCFA), which have been linked to both obesity promotion and diabetes prevention. By comparing the effects of these fibers, the study aims to understand their role in health and disease better. This research is particularly important as it could help improve our understanding of how dietary fiber impacts metabolism and potentially lead to new strategies for managing obesity and diabetes. During this study, participants from both lean and overweight/obese groups consume a drink containing either glucose alone or glucose combined with either inulin or resistant starch. This happens on three separate occasions, following a randomized, single-blind design. The study measures the body's responses, specifically focusing on short-chain fatty acids, glucose, insulin, free fatty acids, and gut hormones. Participants also receive a standard lunch four hours after consuming the test drink. The primary outcome of interest is the incremental area under the serum acetate response curve, which is a measure of how much acetate, a type of short-chain fatty acid, is produced over time.

Official TitleEffect of Inulin and Resistant Starch on Postprandial Short Chain Fatty Acid, Glucose, Insulin and Gut Hormone Responses in Lean and Overweight Subjects.
NCT02562014
Principal SponsorUniversity of Toronto
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

25 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Basic Science Study

Basic science studies help researchers understand how the body works or how a disease develops. They don't test treatments, but they build the foundation for future therapies.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Body WeightNutrition DisordersNutritional and Metabolic DiseasesObesitySigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionOverweight

Criteria

2 inclusion criteria required to participate
non-pregnant

body mass index >=20 and <=35

9 exclusion criteria prevent from participating
history of diabetes mellitus

history of cardiovascular disease

history of bowel disease

history of kidney disease

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Participants with body mass index \<=25

Group II

Participants with body mass index \>25

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers